Professionnels de santé

Grand public

Presse
Ensemble, améliorons la qualité en santé

Home > Professionnels de santé > Actes - Médicaments - Dispositifs médicaux > Médicaments

Transparency Committee Opinion

AFINITOR

Date 13 January 2010
Pharmaceutical
formulation

AFINITOR 5 mg, tablet
B/30 (CIP: 396 281-1)
AFINITOR 10 mg, tablet
B/30 (CIP: 396 282-8)

ATC code
  1. L01XE10
Active ingredient

everolimus
Laboratory / Manufacturer NOVARTIS PHARMA SAS
Reason for request Inclusion on the list of medicines reimbursed by National Insurance and approved for hospital use.

Documents

Tools

For more information

Contacts

Contact évaluation des médicaments

transparence@has-sante.fr


 

TAGS

Urologic cancers - Drug therapy
Haute Autorité de Santé - 2009